A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Data de publicación
2013Título da revista
Annals of the rheumatic diseases
Tipo de contido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)